All OzPep BPC-157 products are supplied as lyophilised research peptides for controlled laboratory use only
Pain Relief Some anecdotal reports suggest that BPC 157 may help reduce stiffness, soreness, or pain during recovery
As a triple receptor agonist targeting GIP, GLP-1, and glucagon pathways simultaneously, it differs structurally and mechanistically from earlier weight management peptides
Its important to note that B12 injections are most effective for patients with a documented deficiency
The properties offered by the compound have also been exploited by a Chinese group, who presented BPC 157 as an interesting component of medical dressings for scar repair, which is effective in shortening the time for wound healing [172]
[1] Marginal deficiency is much more common and may occur in up to 40% of Western populations